Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bleomycin/cisplatin protocol

Known as: BP, Bleomycin/Cisplatin, BLEO/CDDP 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
OBJECTIVE To document safety for use, through recording changes in blood pressure and pulse rate, after administering 3.6 ml of a… Expand
2011
2011
Bone metastases in advanced breast cancer patients remains a significant treatment challenge. Bisphosphonates are now a routine… Expand
2007
2007
The rat streptozotocin (STZ)-induced diabetes model is widely used to investigate the pathogenesis of diabetic nephropathy… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Highly Cited
2006
Highly Cited
2006
To develop stimuli-responsive ultrathin polymer films on a solid substrate, a novel photo-cross-linkable polymer with both… Expand
2002
2002
Angiotensin-converting enzyme (ACE) inhibitors reduce mortality in patients with acute myocardial infarction (AMI), but these… Expand
2000
2000
Objective: To examine prospectively the effects of antihypertensive therapy on office blood pressure (BP) and home BP, in a large… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
1999
1999
Between January and December 1996, we observed 64 children (mean age 8.3 years range 4.2 to 11.2 years) who required dialysis for… Expand
1999
1999
BACKGROUND It has been known since 1953 that pre-exposure to less than +1 Gz will reduce subsequent +Gz-tolerance. With few… Expand
Highly Cited
1998
Highly Cited
1998
Unopposed actions of vasoconstrictors, such as angiotensin, play an important role in the effects of chronic nitric oxide… Expand
  • figure 2
  • figure 3
  • figure 4
  • table 1
  • figure 5
1994
1994
The preventive effect of betamipron (N-benzoyl-3-propionic acid: BP) on the renal uptake and nephrotoxicity of carbapenems… Expand